Ran Xu

860 total citations
25 papers, 654 citations indexed

About

Ran Xu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ran Xu has authored 25 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ran Xu's work include Ferroptosis and cancer prognosis (3 papers), Peptidase Inhibition and Analysis (3 papers) and Immunotherapy and Immune Responses (3 papers). Ran Xu is often cited by papers focused on Ferroptosis and cancer prognosis (3 papers), Peptidase Inhibition and Analysis (3 papers) and Immunotherapy and Immune Responses (3 papers). Ran Xu collaborates with scholars based in China, United States and Norway. Ran Xu's co-authors include Shaomeng Wang, Yi Han, Chao‐Yie Yang, Scott G. Filler, Dimitrios P. Kontoyiannis, Lisa Y. Chiang, Raymond H. Jacobson, Georgios Chamilos, Gregory S. May and Shiqi Ren and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Ran Xu

22 papers receiving 649 citations

Peers

Ran Xu
George W. Yip Singapore
Meike Müller Germany
Zhen Tong United Kingdom
Osamu Yoshida Japan
Frédéric Couture Canada
Qun Li China
Poonam Gautam India
Min Guan China
Xiaoyan Yang China
Sumit Borah United States
George W. Yip Singapore
Ran Xu
Citations per year, relative to Ran Xu Ran Xu (= 1×) peers George W. Yip

Countries citing papers authored by Ran Xu

Since Specialization
Citations

This map shows the geographic impact of Ran Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Xu more than expected).

Fields of papers citing papers by Ran Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Xu. The network helps show where Ran Xu may publish in the future.

Co-authorship network of co-authors of Ran Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Xu. A scholar is included among the top collaborators of Ran Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Xu. Ran Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xin, et al.. (2025). A Hybrid GRU-MHSAM-ResNet Model for Short-Term Power Load Forecasting. Processes. 13(11). 3646–3646.
2.
Xu, Ran, et al.. (2025). Cell-derived exosome therapy for diabetic peripheral neuropathy: a preclinical animal studies systematic review and meta-analysis. Stem Cell Research & Therapy. 16(1). 297–297. 2 indexed citations
3.
4.
5.
6.
Li, Hang, et al.. (2024). Evidence-based practice attitudes, knowledge and skills of nursing students and nurses, a systematic review and meta-analysis. Nurse Education in Practice. 78. 104024–104024. 7 indexed citations
7.
Xu, Ran, et al.. (2024). Establishment of novel colorectal cancer organoid model based on tumor microenvironment analysis. PubMed. 3(4). lnae027–lnae027. 1 indexed citations
8.
Xu, Ran, et al.. (2023). Risk prediction models for deep venous thrombosis in patients with acute stroke: A systematic review and meta-analysis. International Journal of Nursing Studies. 149. 104623–104623. 17 indexed citations
9.
Zhang, Bo, Qiong Wu, Ran Xu, et al.. (2019). The promising novel biomarkers and candidate small molecule drugs in lower‐grade glioma: Evidence from bioinformatics analysis of high‐throughput data. Journal of Cellular Biochemistry. 120(9). 15106–15118. 17 indexed citations
10.
Wu, Qiong, Bo Zhang, Yidan Sun, et al.. (2019). <p>Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis</p>. OncoTargets and Therapy. Volume 12. 3545–3563. 28 indexed citations
11.
Wu, Qiong, Bo Zhang, Ziheng Wang, et al.. (2019). Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer. Pathology - Research and Practice. 215(5). 1038–1048. 16 indexed citations
12.
Zhang, Bo, You Zhou, Ziheng Wang, et al.. (2019). Efficacy and safety of CTLA-4 inhibitors combined with PD-1 inhibitors or chemotherapy in patients with advanced melanoma. International Immunopharmacology. 68. 131–136. 16 indexed citations
13.
Xu, Ran, et al.. (2018). Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer. OncoTargets and Therapy. Volume 11. 8605–8621. 15 indexed citations
14.
Zhang, Xin, Xuehai Wang, Ran Xu, et al.. (2018). YM155 decreases radiation-induced invasion and reverses epithelial–mesenchymal transition by targeting STAT3 in glioblastoma. Journal of Translational Medicine. 16(1). 79–79. 28 indexed citations
15.
Xin, Wei, et al.. (2017). Fc&gamma;RIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Wu, Yingcheng, Ran Xu, Keren Jia, & Hui Shi. (2017). The efficacy of chimeric antigen receptor (CAR) immunotherapy in animal models for solid tumors: A systematic review and meta-analysis. PLoS ONE. 12(11). e0187902–e0187902. 2 indexed citations
17.
Wang, Chunyan, et al.. (2015). Identification of Pivotal Markers in Vascular Dementia Based on Proteomics Data. Dementia and Geriatric Cognitive Disorders. 39(5-6). 312–320. 6 indexed citations
18.
Kurokawa, Manabu, Ji‐Yeon Kim, Joseph Geradts, et al.. (2013). A Network of Substrates of the E3 Ubiquitin Ligases MDM2 and HUWE1 Control Apoptosis Independently of p53. Science Signaling. 6(274). ra32–ra32. 54 indexed citations
19.
Xu, Ran, et al.. (2011). Design of Triazole-Stapled BCL9 α-Helical Peptides to Target the β-Catenin/B-Cell CLL/lymphoma 9 (BCL9) Protein–Protein Interaction. Journal of Medicinal Chemistry. 55(3). 1137–1146. 203 indexed citations
20.
Xu, Ran, Georgios Chamilos, Dimitrios P. Kontoyiannis, et al.. (2008). Gliotoxin Production inAspergillus fumigatusContributes to Host‐Specific Differences in Virulence. The Journal of Infectious Diseases. 197(3). 479–486. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George W. Yip Breakdown of academic impact, for papers by Meike Müller Breakdown of academic impact, for papers by Zhen Tong Breakdown of academic impact, for papers by Osamu Yoshida Breakdown of academic impact, for papers by Frédéric Couture Breakdown of academic impact, for papers by Qun Li Breakdown of academic impact, for papers by Poonam Gautam Breakdown of academic impact, for papers by Min Guan Breakdown of academic impact, for papers by Xiaoyan Yang Breakdown of academic impact, for papers by Sumit Borah
Rankless by CCL
2026